Found: 1

Select item for more details and to access through your institution.

  • SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancer.

    Published in:
    Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-019-08380-1
    By:
    • Xue, Yibo;
    • Meehan, Brian;
    • Fu, Zheng;
    • Wang, Xue Qing D.;
    • Fiset, Pierre Olivier;
    • Rieker, Ralf;
    • Levins, Cameron;
    • Kong, Tim;
    • Zhu, Xianbing;
    • Morin, Geneviève;
    • Skerritt, Lashanda;
    • Herpel, Esther;
    • Venneti, Sriram;
    • Martinez, Daniel;
    • Judkins, Alexander R.;
    • Jung, Sungmi;
    • Camilleri-Broet, Sophie;
    • Gonzalez, Anne V.;
    • Guiot, Marie-Christine;
    • Lockwood, William W.
    Publication type:
    Article